Kodak Expands Pharmaceuticals Portfolio with Four Regulated Products
Eastman Kodak Company Common New (KODK)
US:NYSE Investor Relations:
investor.kodak.com
Company Research
Source: Business Wire
New U.S.-Manufactured PBS and WFI Offerings Deliver Reliable, High-Quality Supply for Labs, Biopharma Industry and CDMOs ROCHESTER, N.Y.--(BUSINESS WIRE)--Eastman Kodak Company (NYSE: KODK) today announced the expansion of its pharmaceuticals portfolio with four new regulated products: KODAK Phosphate Buffered Saline (PBS) 1X in low endotoxin and RNase/DNase/Protease-free formulations, and KODAK Water for Injection (WFI) in standard and RNase/DNase/Protease-free formulations. All are immediately available for order by U.S. research laboratories, biopharma developers, and contract development and manufacturing organizations (CDMOs).The two new PBS formulations join a standard PBS 1X already shipping, while the WFI products represent the first offerings in that category. Customers gain the assurance of lot-traceable products built on Kodak’s rigorous quality processes, including a multi-step water purification system that supports consistently high purity, along with responsive and p
Show less
Read more
Impact Snapshot
Event Time:
KODK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KODK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KODK alerts
High impacting Eastman Kodak Company Common New news events
Weekly update
A roundup of the hottest topics
KODK
News
- Kodak Expands Pharmaceuticals Portfolio with Four Regulated Products [Yahoo! Finance]Yahoo! Finance
- Eastman Kodak: Pension Monetization Gains Countered By Lackluster Core Business [Seeking Alpha]Seeking Alpha
- FOX Business: Kodak's New Focus … A Sharp Turn From Film to Pharma [FOX News]FOX News
- Kodak Completes Pension Reversion Process, Delivering Over $1 Billion to Strengthen Balance Sheet, Fully Fund New Benefit Plan, and Accelerate GrowthBusiness Wire
- Eastman Kodak Stock Down 13% But Insiders Still In US$88k Profit [Yahoo! Finance]Yahoo! Finance
KODK
Sec Filings
- 1/21/26 - Form SCHEDULE
- 1/16/26 - Form 4
- 1/7/26 - Form 4
- KODK's page on the SEC website